Voxzogo (vosoritide)

11,108.14

Voxzogo (vosoritide) is a prescription medicine used to treat achondroplasia in children aged 2 years and older whose bones are still growing.

DISEASE INDICATIONS

Achondroplasia

MANUFACTURER

BioMarin Europe Ltd

USAGE

Subcutaneous

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
VOXZOGO (VOSORITIDE) Package

One vial with 0.4 mg powder + prefilled syringe with water, One vial with 0.56 mg powder + prefilled syringe with water, One vial with 1.2 mg powder + prefilled syringe with water

Reviews

There are no reviews yet.

Be the first to review “Voxzogo (vosoritide)”

Your email address will not be published. Required fields are marked *

Shopping Cart